In short: The structural answer to the funding gap: after the DFC and Standard Bank conditions are met, a further $250m must be raised, and "Noble Africa will be the only listed helium company on Nasdaq — any dilution should fall on it. ASPI to retain 89% ownership." Frodsham2866 adds his own caveat: "Not sure how that works with the dilution though they do have plenty of cash for that purpose." Not yet trading — no stance on price, only on the mechanism.
Noble Africa is the entity ASP Isotopes intends to list on Nasdaq to hold the helium business. Its role in this call is financing plumbing: after the DFC and Standard Bank conditions are satisfied, another $250m of equity is needed, and management says that money will be raised at the Noble Africa level rather than at ASPI's — "any dilution should fall on it," with ASPI keeping 89% of the subsidiary afterwards.
"Dilution" simply means issuing new shares so existing holders own a smaller slice. Doing it at a subsidiary is a way to fund a project without shrinking the parent's shareholders' stake in everything else the parent owns — though the parent's share of the subsidiary still falls, which is exactly what the 89% figure describes. The member who attended flagged honest uncertainty here: "Not sure how that works with the dilution though they do have plenty of cash for that purpose." Until the listing documents exist this is a stated intention rather than a completed structure, which is why the stance is neutral — no view on price, only on the mechanism.
In short: "We announced back in July that we intend to merge this asset into a NASDAQ company called Endra [as heard]. And this will then become the focus of that company and this becomes the first helium pure-play company listed on NASDAQ that's actually producing helium." A stated intention, not a completed transaction — and the only mention of it in this appearance. The auto-transcript hearing is unreliable; the same-day Red Chip readout names the vehicle Noble Africa (ASPI retaining 89%, and the designated home for the residual $250m equity raise), so it is filed under that id here.
The helium business is not meant to stay buried inside ASP Isotopes. In July the company announced it intends to merge the asset into an existing Nasdaq-listed company, which would then become, in Mann's words, "the first helium pure-play company listed on NASDAQ that's actually producing helium." A pure-play is simply a company whose business is one thing, so an investor can buy the helium exposure without also buying the isotope and medicine divisions.
Two cautions. First, this is a stated intention, given in one sentence and with no mechanics attached — hence the neutral stance until listing documents exist. Second, the auto-generated transcript hears the vehicle's name as "Endra," which is almost certainly a mis-transcription; the same-day member readout of the Red Chip call names it Noble Africa, adds that ASP Isotopes would retain 89%, and identifies it as where a further $250m equity raise (and therefore any dilution) is meant to land. That last mechanism — how a parent's shareholders avoid dilution when a subsidiary sells shares — is exactly the detail that needs a filing to confirm.
7:33We announced back in July that we intend to merge this asset into a NASDAQ company called Endra [as heard]. And this will then become the focus of that company and this becomes the first helium pure-play company listed on NASDAQ that's actually producing helium. So it's very exciting. It's a very unique asset, helium.
Nothing matches this filter.
Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.